Trial Slated For Monday In Wyeth Hormone Drug Case

Law360, New York (August 17, 2006, 12:00 AM EDT) -- The first of thousands of personal injury lawsuits against Wyeth over the company’s hormone therapy drugs, which were used to treat the symptoms of menopause, is slated to begin on Monday.

As of July 24, Wyeth faced a total of approximately 5,000 legal actions brought on behalf of 8,300 women across the country. The actions are based on personal injury claims stemming from the use of Wyeth’s hormone therapy drugs Premarin and/or PremPro.

Wyeth has earmarked more than $21 billion dollars to deal with the litigation...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.